Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-23

Clinical Trial Update: Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone

View source ↗

Summary

A clinical trial update reports on the long-term use of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Schizophrenia, Schizoaffective Disorder | Status: COMPLETED